home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Molecular Basis For A Skin Fragility Syndrome

  April, 28 2001 3:32
your information resource in human molecular genetics
In the May issue of Nature Cell Biology (Vol. 3, No. 5, pp. 503-506), Pierre Coulombe and colleagues, of the Johns Hopkins University School of Medicine in Baltimore, USA, describe the molecular effect of one mutation commonly found in a keratin gene of patients affected by the skin fragility disorder epidermolysis bullosa simplex (EBS).

Keratins are proteins that form rod-like structures and assemble as a criss-crossed web within skin cells to give them structure and support from outside pressure. (Just imagine what’s happening to these cells when someone squeezes your arm or pinches your skin!) In EBS, mutations can occur in two of the many keratin genes present in skin cells. Coulombe and coworkers describe the mechanical properties of one of these defective keratin proteins. The mutation in keratin 14 changes a single amino acid, with dramatic effect. Whereas the normal protein makes filaments which then form bundles, like a sheaf of wheat, the mutated keratin protein cannot form the bundles, and consequently produces keratin networks that are more prone to breaking under stress. In addition, this mutant keratin makes filaments of greatly varying lengths, another factor expected to lower a cell’s resilience to external stress.

Whilst these results suggest how this particular mutation might contribute to the manifestation of EBS, further studies are required to determine how other keratin-based disorders, which do not affect filament structure so obviously, cause similar skin fragility diseases.

Pierre Coulombe
tel +1 410 614 0510
e-mail pacoulom@welchlink.welch.jhu.edu

(C) Nature Cell Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.